Figure 2 | Scientific Reports

Figure 2

From: Anti-SARS-CoV-2 antibody levels and kinetics of vaccine response: potential role for unresolved inflammation following recovery from SARS-CoV-2 infection

Figure 2

Antibody levels following vaccination (baseline—T0, 20 days after first dose—T1, 14 days after 2nd dose—T2): pattern shape, coefficients and goodness-of-fit parameters for the sub-population groups identified from trajectory analyses (best model), in the overall sample with repeated serum IgG measurements at T0, T1 and T2 (n = 137). Y log scale. ^: On the log-transformed serum IgG variable; nr not relevant (linear model); *: Bayesian Information Criterion, on the number of observations (n = 137 unique subjects, 3 time measurement each); **: Bayesian Information Criterion, on the number of unique subjects (n = 137 unique subjects).

Back to article page